-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GuH/NFTlP49ON6iEPfw/z9SYwI/6zzASCeTW2/CkPIptT6VvreWqzCZ/RclKro/e SKrMWNQvXCOHCFpQz9n59Q== 0000950123-09-047572.txt : 20091001 0000950123-09-047572.hdr.sgml : 20091001 20091001105312 ACCESSION NUMBER: 0000950123-09-047572 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090930 ITEM INFORMATION: Other Events FILED AS OF DATE: 20091001 DATE AS OF CHANGE: 20091001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Graymark Healthcare, Inc. CENTRAL INDEX KEY: 0001272597 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 200180812 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34171 FILM NUMBER: 091097510 BUSINESS ADDRESS: STREET 1: 101 N. ROBINSON STREET 2: SUITE 920 CITY: OKLAHOMA CITY STATE: OK ZIP: 73102 BUSINESS PHONE: 4056015300 MAIL ADDRESS: STREET 1: 101 N. ROBINSON STREET 2: SUITE 920 CITY: OKLAHOMA CITY STATE: OK ZIP: 73102 FORMER COMPANY: FORMER CONFORMED NAME: GRAYMARK PRODUCTIONS INC DATE OF NAME CHANGE: 20031210 8-K 1 d69375e8vk.htm 8-K e8vk
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 30, 2009
GRAYMARK HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
         
Oklahoma   001-34171   20-0180812
(State or other jurisdiction
of incorporation) 		  (Commission File Number)   (I.R.S. Employer
Identification No.)
     
210 Park Avenue, Suite 1350
Oklahoma City, Oklahoma 73102 		  73102
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (405) 601-5300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14a-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

Item 8.01 Other Events.
We, at Graymark Healthcare, Inc., hereby report, effective September 30, 2009, the appointment of Lewis P. Zeidner as our Chief Operating Officer. Joseph Harroz, Jr., formerly appointed dual roles of President and Chief Operating Officer, will continue in his role as our President and a member of our Board of Directors.
In light of recent acquisitions and resulting expansion of our wholly owned subsidiary, SDC Holdings, LLC, which more than doubled its size, a realignment of duties and expansion of executive structure is necessary. In addition to other benefits, this change will allow for additional focus by Mr. Harroz on acquisition opportunities. Mr. Zeidner has served as President and Chief Executive Officer of our wholly owned subsidiary, ApothecaryRx LLC, since its founding in 2006 and will continue in this role.

 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  GRAYMARK HEALTHCARE, INC.
(Registrant)
 		  
  By:   /s/ STANTON NELSON    
         Stanton Nelson, Chief Executive Officer   
       
 
Date: September 30, 2009

-----END PRIVACY-ENHANCED MESSAGE-----